Bundamedik Tbk vs Ketrosden Triasmitra Tbk. — how do they compare? Bundamedik Tbk trades at Rp177 (market cap 1.51T, 32.3K 24h volume), while Ketrosden Triasmitra Tbk. trades at Rp535 (market cap 1.49T, 965.6K 24h volume). The key difference: Bundamedik Tbk and Ketrosden Triasmitra Tbk. are close in size by market cap, and Ketrosden Triasmitra Tbk. is more actively traded (965.6K versus 32.3K). Which is the better fit depends on your goals.
| BMHS | KETR | |
|---|---|---|
Market Cap | 1.51T | 1.49T |
Volume | 32.3K | 965.6K |
Lot | 323 | 9.66K |
Turnover | 5.71M | 512.67M |
Average Price | 176.67 | 530.93 |
Value | 5.71M | 512.67M |
Indicative Equilibrium Price | 177 | 525 |
Indicative Equilibrium Volume | 108 | 40.8K |
Trailing returns across standard periods
Latest headlines on both assets
PT Bundamedik Tbk (the “Company”) was established on 13 April 1978 based on Notarial Deed No. 21 of Adlan Yulizar, S.H. The Company strated its commercial operations in 1978. The Company’s parent and ultimate parent of the group is PT Bunda Investama Indonesia.
Read more on BMHS →PT Ketrosden Triasmitra Tbk was established base on Notarial Deed No.179 of Pudji Redjeki Irawati S.H., dated November 25, 1994.
Read more on KETR →